We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Microbicides — pathogen-stopping gels or creams that can be used before sexual intercourse — are a promising but undeveloped strategy for fighting HIV infection.

Although the idea has been around for many years, no microbicide has been proved clinically effective against the virus. But advocates have reason to be optimistic.

In this article, Rebecca Spieler Trager describes recent progress in the development of microbicides, and reports that a new non-profit group — already backed by US$30 million of funding — is opening this month in Maryland, United States to advance the technology.

Link to Science article

Reference: Science 299, 39 (2002)

Related topics